Clinical Trials Browser

Phase 1/2 × Solid Tumor, Adult × spartalizumab × Clear all

NCT06265727 2026-01-08

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult